Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 23, 2012

View Archived Issues

Meningitis B vaccine is immunogenic in adolescents in phase IIb/III trial

Novel dual modulators of serotonin 5-HT2A and dopamine D3 receptors reported

Idera Pharmaceuticals reports phase Ib data on IMO-2055

Chiesi Farmaceutici patents new muscarinic acetylcholine M receptor antagonists

Everolimus improves survival of patients with gastrointestinal cancer

FDA lifts clinical hold placed on Arikace program

Traditional medicine ameliorates chemotherapy-induced nausea and vomiting

Novel constrained vaccines created in Australia

CHMP issues opinion on Folotyn

Capstone Therapeutics terminates development of two products

New statin derivatives reported by NicOx

Medicago expands on rabies vaccine development

Novartis announces CHMP opinion on Signifor

Novel glucagon analogues described

Sandoz begins two phase III trials of biosimilars

Novel GlyT-1 inhibitors reported by Roche

MEK-162 investigated in biliary tract cancer

Enrollment opens in phase III PRESENT study of NeuVax

Intravenous Bonalon approved in Japan

EMA reviews Gilenya following reports of heart problems in patients

OncoSec Medical updates corporate progress

EMA recommends marketing suspension for meprobamate-containing medicines

FDA committee against approval of vaginal gel to reduce preterm birth

FDA offers guidance on EpiCept's AmiKet program

Study investigates tasquinimod/cabazitaxel combination in prostate cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...